NCT07137533

Brief Summary

This study compares long-term peri-implant outcomes between two mandibular full-arch rehabilitation approaches-four-implant-retained overdentures and All-on-4 fixed prostheses-when both are fabricated with polyetheretherketone (PEEK) frameworks. While overdentures and All-on-4 prostheses are widely used, evidence on the clinical performance of PEEK frameworks in these modalities is scarce. By evaluating marginal bone loss and other peri-implant parameters, the research aims to clarify whether prosthetic design influences biological outcomes when using this high-performance polymer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2025

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

August 15, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2025

Completed
Last Updated

August 22, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

August 15, 2025

Last Update Submit

August 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Marginal Bone Loss (MBL) per implant (mm)

    Definition: Change in crestal bone level on the mesial and distal aspects of each implant from baseline to last follow-up. Baseline: Prosthesis delivery (insertion) radiograph. Follow-up window: Minimum 48 months post-insertion (target range ≈ 4-9 years, depending on patient record length). Measurement method: Standardized periapical radiographs using a paralleling technique

    5 years

Study Arms (2)

Group A - Overdenture Group

Patients in this group received four parallel implants placed in the interforaminal region-two in the lateral incisor sites and two in the first premolar sites. The implants supported a removable overdenture retained by a CAD/CAM-fabricated PEEK framework. The overdentures were designed for improved retention, stability, and load distribution, with acrylic resin denture teeth.

Other: Mandibular Four-Implant-Retained Overdenture (PEEK Framework); Mandibular All-on-4 Fixed Prosthesis (PEEK Framework)

Group B - Fixed Prosthesis Group

Patients in this group received four implants according to the All-on-4 protocol-two anterior straight implants in the lateral incisor region and two posterior tilted implants in the first premolar region. The implants supported a screw-retained full-arch fixed prosthesis with a CAD/CAM-fabricated PEEK framework and acrylic resin denture teeth. The design aimed to optimize anteroposterior spread and reduce cantilever length while providing a fixed restoration.

Other: Mandibular Four-Implant-Retained Overdenture (PEEK Framework); Mandibular All-on-4 Fixed Prosthesis (PEEK Framework)

Interventions

Group I: Four-implant-retained mandibular overdenture with a CAD/CAM-milled PEEK framework and acrylic denture teeth, retained via attachment mechanisms; implants placed in lateral incisor and first premolar sites; delayed loading protocol. Group II: Mandibular All-on-4 fixed prosthesis with a CAD/CAM-milled PEEK framework and acrylic denture teeth; two anterior straight and two posterior tilted implants placed in lateral incisor and first premolar sites; delayed loading protocol.

Group A - Overdenture GroupGroup B - Fixed Prosthesis Group

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consisted of adult patients with completely edentulous mandibles who underwent full-arch implant-supported rehabilitation between 2015 and 2018 at two private dental clinics. Eligible patients had been restored with either a four-implant-retained mandibular overdenture or an All-on-4 mandibular fixed prosthesis, both fabricated with CAD/CAM-milled polyetheretherketone (PEEK) frameworks and acrylic denture teeth. All implants were placed in the inter foraminal region, following a delayed loading protocol.

You may qualify if:

  • Adults aged ≥40 years.
  • Completely edentulous mandible for at least 6 months prior to implant placement.
  • Treated with either:
  • Four-implant-retained mandibular overdenture with a PEEK framework, or
  • Mandibular All-on-4 fixed prosthesis with a PEEK framework.
  • All implants placed in the lateral incisor and first premolar regions (per respective protocol).
  • Restorations fabricated via CAD/CAM-milled PEEK framework with acrylic denture teeth.
  • Prosthesis delivered with a delayed loading protocol.
  • Minimum clinical and radiographic follow-up of 4 years.
  • Availability of standardized baseline and follow-up periapical radiographs for marginal bone level assessment.
  • Treated by the same surgical and prosthodontic team.

You may not qualify if:

  • History of uncontrolled systemic diseases that could affect bone healing (e.g., uncontrolled diabetes, osteoporosis under bisphosphonate therapy).
  • History of head and neck radiotherapy.
  • Active periodontal or peri-implant infection at the time of implant placement.
  • Insufficient bone volume in the interforaminal region requiring grafting beyond minor augmentation.
  • Heavy smoking habit (\>10 cigarettes/day) at the time of treatment.
  • Parafunctional habits (e.g., severe bruxism or clenching) documented in patient records.
  • Use of medications known to affect bone metabolism (e.g., high-dose corticosteroids, antiresorptive drugs).
  • Pregnancy at the time of implant placement.
  • Incomplete clinical or radiographic records.
  • Follow-up period of less than 4 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry

Shibīn al Kawm, Menoufia, Egypt

RECRUITING

Central Study Contacts

Mohammed A. El-Sawy, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

August 15, 2025

First Posted

August 22, 2025

Study Start

August 1, 2025

Primary Completion

October 1, 2025

Study Completion

October 25, 2025

Last Updated

August 22, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Up on resonable request from the corresponding author

Locations